ClinicalTrials.Veeva

Menu

Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum

N

National Yang Ming Chiao Tung University

Status

Completed

Conditions

Randomized Controlled Trial

Treatments

Other: Baduanjin program

Study type

Interventional

Funder types

Other

Identifiers

NCT04071444
2-107-05-114

Details and patient eligibility

About

Patients with schizophrenia spectrum have been suffering from constipation due to long-term use of psychotropic medications and changes in physical activity and eating habits caused by diseases.

Aim this study was to examine the effectiveness of Baduanjin program in improving the symptoms of intestinal peristalsis and constipation in patients with psychosis.

Method:A randomized controlled trial was conducted in tow psychiatric centers in northern Taiwan.The experimental group was provided with an 8- session Baduanjin program for 24 weeks (1 hour, thrice times per week), while the control group received routine care.

Full description

This study was conducted in two psychiatric center. Residents in one of psychiatric center were allowed to walk for 20 min after dinner every day, and each unit residents rare active. In this study, patients on the schizophrenia spectrum were invited to receive screening for constipation syndrome. A total of 275 patients agreed to undergo the screening. In total of 112 patients satisfied the inclusion criteria, and 58 patients consented to participate in the experiment.

Each participant was assigned one number from 1 to 112 by the first author. The second author enrolled participants. They were randomized to either Baduanjin program group or routine care group in a 1:1 ratio using blocked randomization having a block size of 3. Patients in the experimental group (EG) participated in the Baduanjin intervention in a privacy setting", which involved 60-min sessions 3 times per week, 1 hour after dinner between 6 and 7 pm; the entire program continued for 24 weeks. The control group (CG) received routine care. The outcome indicators for this intervention program involved the risk factors for constipation, constipation symptoms, and Intestinal Peristalsis.

Enrollment

112 patients

Sex

All

Ages

20 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Comply with the diagnosis of the spectrum.
  • Have the willingness to participate in the study and could read, communicate and cooperate with the completion of the consent form and questionnaire.
  • The age is 20 to 64 years old.
  • No need for any assistance in walking, and the gait is stable.
  • Appeared more than 2 times in the past month for more than 3 consecutive days without resolving or routine use of laxatives

Exclusion criteria

  • Diagnosis is organic brain disease, alcohol and substance abuse.
  • There have been problems with gastrointestinal bleeding or lesions.
  • Have a history of extensive abdominal surgery or gastrointestinal surgery.
  • There are medical considerations and medical expenses reduction activities.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

112 participants in 2 patient groups

Baduanjin program
Experimental group
Description:
The entire program continued for 6 months (December, 2018 to July, 2019), and the intervention was performed for 60 min 3 times per week; particular attention was paid to the disease characteristics of the patients with chronic schizophrenia and to preventing excessive fatigue. Every session began with a 20-min warm-up, followed by 20 min of Baduanjin program, and ended with a cool-down session. The participants were instructed, with the assistance of a video, to practice Baduanjin program in a group by two authors who are experienced in the psychiatric nurses and had been trained in this program.
Treatment:
Other: Baduanjin program
Control group
No Intervention group
Description:
The control group (CG) received routine care.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems